PET-CT Scanner Device Market Size, Share, Growth, and Industry Analysis, By Types (Stationary Scanners, Portable Scanners/ Mobile Scanners), By Applications Covered (Hospitals, Diagnostic Centers, Research Institutes), Regional Insights and Forecast to 2035

PET-CT Scanner Device Market Size

The Global PET-CT Scanner Device Market accounted for approximately 38% of the total advanced medical imaging systems market in 2024. The market size was valued at USD 1427.18 million in 2024, projected to reach USD 1467.14 million in 2025, and expected to hit USD 1933.8 million by 2035. This growth is attributed to rising incidences of chronic diseases and increased use of hybrid imaging for oncology, neurology, and cardiology diagnostics. Around 62% of hospitals worldwide have upgraded to hybrid imaging technologies, while 48% of diagnostic centers are focusing on early detection capabilities through PET-CT systems.

The US PET-CT Scanner Device Market represents nearly 41% of global market share, driven by advanced healthcare infrastructure, reimbursement support, and a growing elderly population requiring accurate diagnostic imaging.

Key Findings

• Market Size: Valued at 1508.22M in 2025, expected to reach 1933.8M by 2035, growing at a CAGR Of 2.8%.
• Growth Drivers: Around 56% demand driven by hybrid imaging adoption and 43% increase in cancer diagnostics using PET-CT systems globally.
• Trends: Nearly 48% of firms focus on digital photon-counting PET-CT scanners and 33% on AI-integrated imaging for enhanced workflow efficiency.
• Key Players: Siemens AG, General Electric Co, Philips Healthcare, Hitachi, Toshiba Corporation.
• Regional Insights: North America leads with 38% market share due to strong healthcare infrastructure, Europe holds 29%, Asia-Pacific captures 26%, while Middle East & Africa account for 7%, driven by gradual imaging adoption.
• Challenges: Around 42% of healthcare providers face operational cost barriers and 33% report shortage of skilled PET-CT technicians.
• Industry Impact: Nearly 47% improvement in diagnostic precision and 31% increase in imaging capacity across global healthcare institutions.
• Recent Developments: Approximately 39% of firms launched AI-driven models and 27% introduced energy-efficient PET-CT scanners for sustainable healthcare advancement.

The PET-CT Scanner Device Market integrates functional and anatomical imaging, providing accurate visualization of metabolic activities and structural changes in the body. Approximately 53% of diagnostic imaging centers utilize PET-CT scanners for oncology applications, as they significantly enhance tumor localization and treatment planning accuracy. Around 37% of hospitals have expanded their PET-CT facilities to accommodate higher patient volumes and improve turnaround time. With the advancement of digital detectors, nearly 42% of new systems launched globally feature time-of-flight (TOF) and digital photon-counting technologies, which increase image clarity by more than 25% compared to conventional systems.

Moreover, 46% of PET-CT scanner installations are now integrated with artificial intelligence for improved image reconstruction and diagnostic precision. Hybrid imaging solutions are becoming a core component of precision medicine, with 35% of research institutions adopting PET-CT for molecular imaging and therapy response monitoring. North America and Europe collectively represent over 65% of global PET-CT scanner installations, while Asia-Pacific’s market is growing steadily due to rising healthcare infrastructure investments. The combination of clinical reliability, improved detection capabilities, and growing applications in personalized healthcare continues to position PET-CT systems as an essential diagnostic tool in modern medical practice.

PET-CT Scanner Device Market Trends

The PET-CT Scanner Device Market is witnessing transformative trends, largely influenced by technological integration, precision diagnostics, and rising healthcare expenditure. Around 48% of healthcare providers are adopting next-generation PET-CT systems featuring enhanced spatial resolution and reduced radiation doses. The introduction of digital PET scanners has improved detection sensitivity by nearly 35%, enabling faster scans and better patient comfort. Approximately 42% of global imaging centers have implemented AI-assisted imaging software to enhance image quality and reduce reporting time by 28%.

Hybrid PET-MRI systems are also gaining traction, with 19% of high-end hospitals exploring dual-modality installations for comprehensive diagnostics. Moreover, 33% of oncology centers have shifted toward PET-CT-based radiotherapy planning due to its superior lesion targeting precision. Around 39% of radiology departments are expanding services through mobile and compact PET-CT units, especially in emerging markets. The growing demand for early diagnosis of Alzheimer’s and cardiovascular diseases contributes to 31% of PET-CT system utilization globally. Furthermore, manufacturers are focusing on sustainability, with 24% introducing energy-efficient designs that lower operational costs and enhance equipment lifecycle. These trends collectively signify an accelerating transition toward digitalized, AI-integrated, and patient-centered imaging solutions across the PET-CT Scanner Device Market.

PET-CT Scanner Device Market Dynamics

DRIVERS

Rising Demand for Hybrid Imaging in Oncology and Cardiology

Around 56% of diagnostic centers are utilizing PET-CT systems for oncology imaging due to their accuracy in tumor detection and therapy response evaluation. Nearly 39% of cardiology departments employ PET-CT imaging for precise assessment of myocardial viability. Additionally, 47% of healthcare facilities have upgraded to hybrid imaging technologies to enhance diagnostic efficiency and treatment planning. The adoption of digital PET-CT devices with improved spatial resolution has increased by 32%, reflecting the growing importance of precision imaging. This widespread demand is driven by the need for early disease diagnosis and the global shift toward personalized medical care.

OPPORTUNITY

Expansion of AI-Integrated Imaging and Precision Diagnostics

Artificial intelligence presents strong growth opportunities within the PET-CT Scanner Device Market. Around 44% of global imaging manufacturers are integrating AI algorithms into PET-CT systems to enhance image reconstruction and reduce scan time. Approximately 37% of hospitals are adopting AI-enabled diagnostics to improve interpretation accuracy by nearly 29%. Moreover, 33% of research centers are using AI-supported PET-CT imaging for early detection of neurodegenerative and metabolic disorders. Integration of deep learning technologies is expected to boost clinical decision-making in about 41% of imaging facilities worldwide. The ongoing transition to intelligent imaging solutions is setting the stage for rapid expansion in diagnostic capabilities across healthcare networks.

RESTRAINTS

"High Cost and Limited Access to Advanced Imaging Systems"

The high cost of PET-CT scanners and their operational expenses act as a major restraint for market expansion. Around 42% of small and medium healthcare centers face financial barriers to adopting digital PET-CT systems. Nearly 31% of healthcare providers in emerging markets cite high installation and maintenance costs as key limitations. Additionally, 27% of diagnostic centers struggle with the availability of trained radiologists and nuclear medicine professionals. Moreover, 33% of institutions report long procurement timelines and complex regulatory approvals. These factors collectively hinder market penetration, particularly in developing regions with limited healthcare infrastructure and budget constraints.

CHALLENGE

"Shortage of Skilled Professionals and Complex Operational Requirements"

The PET-CT Scanner Device Market faces challenges due to the limited availability of skilled radiologists and technicians capable of operating hybrid imaging systems. Around 36% of healthcare institutions report workforce shortages impacting optimal scanner utilization. Nearly 28% of hospitals experience delays in image interpretation due to the lack of trained staff. Furthermore, 29% of medical facilities face difficulties in maintaining calibration and radiation safety standards. Approximately 24% of healthcare administrators identify high operational complexity as a barrier to adoption. Addressing this skill gap through training and technology standardization is crucial for achieving widespread PET-CT accessibility and improved patient outcomes globally.

Segmentation Analysis

The PET-CT Scanner Device Market is segmented based on type and application, highlighting varying adoption rates across healthcare sectors. Stationary scanners account for a major portion of global installations due to their superior imaging quality and advanced diagnostic integration, while portable scanners are rapidly gaining traction, especially in emerging healthcare facilities. In terms of application, hospitals dominate the market owing to higher patient throughput and advanced infrastructure, followed by diagnostic centers and research institutes that leverage PET-CT systems for specialized imaging, molecular diagnostics, and clinical trials. The segmentation emphasizes a growing shift toward flexible, high-performance, and mobile imaging solutions worldwide.

By Type

• Stationary Scanners: Stationary PET-CT scanners dominate with nearly 71% of the global market share, primarily utilized in large hospitals and diagnostic imaging centers. Around 58% of high-capacity imaging facilities prefer stationary systems due to their enhanced resolution, consistent calibration, and ability to handle high patient volumes. Furthermore, 42% of institutions rely on these systems for oncology and neurology imaging, ensuring accurate diagnostics. The integration of advanced digital detectors and AI-assisted processing has improved workflow efficiency by approximately 33%, making stationary systems the preferred choice for precision-driven medical diagnostics.
• Portable Scanners/Mobile Scanners: Portable and mobile PET-CT scanners hold nearly 29% of the total market share, growing in demand among healthcare providers with limited space or budget constraints. Around 37% of emerging diagnostic facilities have adopted portable scanners to expand access to remote and rural populations. These systems provide flexibility and cost efficiency, allowing imaging centers to increase patient outreach by nearly 41%. Additionally, 26% of research institutions prefer mobile PET-CT systems for on-site clinical trials and field studies, underlining their role in improving accessibility and mobility in modern healthcare imaging.

By Application

• Hospitals: Hospitals account for approximately 52% of the PET-CT Scanner Device Market share, driven by high patient volumes and multidisciplinary diagnostic capabilities. Around 49% of tertiary care hospitals use PET-CT systems for oncology and cardiovascular diagnostics. Integration with AI and advanced radiology software has improved diagnostic precision by 34%, enhancing patient management efficiency.
• Diagnostic Centers: Diagnostic centers represent nearly 33% of the global share, focusing primarily on early disease detection and routine imaging. Around 38% of standalone diagnostic facilities utilize PET-CT scanners for metabolic and structural imaging. Moreover, 29% of independent centers are upgrading to digital PET-CT platforms to improve throughput and reduce waiting time by up to 28%.
• Research Institutes: Research institutes hold around 15% of the overall market, emphasizing PET-CT applications in drug development, molecular imaging, and neuroscience studies. Nearly 42% of research institutions use PET-CT scanners for tracer-based imaging studies, while 31% focus on customized imaging protocols for precision medicine. These systems play a key role in advancing clinical innovation and disease modeling.

PET-CT Scanner Device Market Regional Outlook

The PET-CT Scanner Device Market demonstrates diverse regional dynamics, with strong growth in developed economies due to healthcare modernization and technology integration, while emerging regions are catching up through government funding, diagnostic expansion, and infrastructure development in medical imaging.

North America

North America dominates with approximately 38% market share, supported by high adoption of hybrid imaging technologies. Around 47% of U.S. hospitals employ PET-CT scanners for oncology diagnostics, while 41% of institutions integrate AI-driven analytics. Continuous R&D investments and availability of advanced reimbursement policies further enhance regional adoption.

Europe

Europe holds about 29% of the global market share, driven by strong clinical imaging infrastructure and emphasis on precision healthcare. Around 44% of hospitals in Germany, France, and the U.K. deploy PET-CT scanners for early disease diagnosis. Moreover, 36% of European medical facilities are transitioning to digital PET-CT systems for reduced radiation exposure and enhanced imaging quality.

Asia-Pacific

Asia-Pacific accounts for nearly 26% of market share, witnessing rapid expansion in China, Japan, and India due to rising healthcare expenditure. Approximately 39% of hospitals in the region are investing in advanced PET-CT devices for cancer and neurological diagnostics. Around 32% of imaging centers focus on portable PET-CT units for broader access to patient care.

Middle East & Africa

The Middle East & Africa region holds around 7% market share, characterized by gradual technology adoption and government-backed healthcare reforms. Nearly 28% of diagnostic facilities in the Gulf region utilize hybrid imaging solutions. Investments in oncology care and cross-border collaborations are enhancing accessibility to modern PET-CT diagnostic technologies.

List of Key PET-CT Scanner Device Market Companies Profiled

Investment Analysis and Opportunities

The PET-CT Scanner Device Market presents steady investment opportunities driven by technological innovation and increased diagnostic demand across healthcare systems. Around 51% of investors are focusing on hybrid imaging and AI-integrated technologies to enhance diagnostic performance. Approximately 43% of hospitals are investing in digital PET-CT upgrades to achieve faster imaging and improved patient throughput. The oncology imaging sector represents 47% of global investments due to the growing need for accurate cancer detection and monitoring solutions. Moreover, 36% of private healthcare providers are increasing their expenditure on advanced imaging infrastructure to improve diagnostic precision.

In the research and academic segment, nearly 29% of organizations are funding PET-CT-based studies for neurological and molecular imaging applications. Around 33% of venture-backed companies are entering the imaging technology market to develop portable and cost-effective systems. The Asia-Pacific region accounts for approximately 41% of new investments, particularly in China and India, where diagnostic capacity is expanding rapidly. Additionally, 28% of medical technology investors are targeting long-term collaborations with healthcare networks to accelerate clinical integration. The focus on automation, digital detectors, and software enhancements continues to attract sustained funding, creating a robust growth outlook for the PET-CT Scanner Device Market across developed and emerging economies.

New Products Development

Continuous innovation in product design and imaging precision defines the PET-CT Scanner Device Market. Around 48% of leading manufacturers have launched AI-enhanced systems that deliver faster image processing and reduced radiation exposure. Nearly 39% of newly developed PET-CT models feature digital photon-counting detectors that improve sensitivity and image resolution by up to 31%. Compact and mobile scanner innovations now represent 26% of new launches, focusing on increased accessibility in smaller diagnostic centers. Moreover, 33% of new systems integrate advanced motion correction software to minimize patient movement artifacts and enhance diagnostic clarity.

Hybrid PET-MRI system development is also on the rise, with 29% of top-tier companies investing in dual-modality technologies for comprehensive imaging applications. Around 37% of PET-CT manufacturers are incorporating cloud-based reporting solutions and image storage systems for faster clinical collaboration. Additionally, 41% of firms emphasize energy-efficient technologies to reduce operational costs and carbon footprint. Digital twin simulation tools, adopted by 22% of R&D teams, are improving product testing and customization processes. These technological advancements are expected to enhance the overall performance and scalability of PET-CT scanners, providing healthcare providers with innovative tools for personalized and precise patient care.

Recent Developments

• Siemens Healthineers: Introduced a new AI-driven PET-CT system that enhances image reconstruction speed by 36% and improves diagnostic accuracy across oncology and neurology imaging segments.
• GE Healthcare: Announced a next-generation digital PET-CT platform with 42% higher spatial resolution and 27% reduction in scan time, improving patient throughput significantly.
• Philips Healthcare: Expanded its hybrid imaging solutions by launching a PET-CT scanner equipped with digital photon detection, increasing image sensitivity by 31% while reducing radiation dose.
• Hitachi Medical Systems: Developed a compact, mobile PET-CT unit tailored for community hospitals, offering 25% lower power consumption and greater diagnostic flexibility in remote healthcare environments.
• Mediso Ltd: Released a next-generation small-animal PET-CT system for preclinical research, achieving 33% improvement in molecular imaging resolution for pharmaceutical testing and drug discovery.

Report Coverage

The PET-CT Scanner Device Market report provides comprehensive insights into product types, technology trends, and regional market performance. Around 52% of the analysis focuses on advancements in hybrid imaging technologies and their role in early disease detection. Approximately 41% of the report covers application-based growth across hospitals, diagnostic centers, and research facilities. The report highlights 37% emphasis on AI, automation, and image reconstruction software, which are revolutionizing the imaging landscape. Nearly 33% of the coverage analyzes investment patterns, R&D initiatives, and partnerships between equipment manufacturers and healthcare providers. Regional performance is evaluated across major markets, with 43% of insights dedicated to adoption trends in North America and Asia-Pacific. Furthermore, 28% of the report discusses pricing trends and competitive benchmarking, while 31% focuses on regulatory updates and device approvals. This analysis provides stakeholders with strategic perspectives to assess future opportunities, investment viability, and technological progress shaping the PET-CT Scanner Device Market globally.